Core Viewpoint - Yong'an Xing announced a change in the lead financial advisor for the ongoing project involving Shanghai Hamao Business Consulting Co., Ltd. and Yang Lei due to the work relocation of the previous advisor [1] Group 1 - Yong'an Xing received a notification from China International Capital Corporation (CICC) regarding the change of the lead financial advisor for the project [1] - The original advisors, Song Yimeng, Wang Liao Jun, and Mao Yue, were responsible for the continuous supervision of the project [1] - Li Yang has been appointed to replace Wang Liao Jun to ensure the continuity of the supervisory work [1]

证券日报网讯 11月26日晚间，东兴证券发布公告称，公司与中国国际金融股份有限公司（简称"中金公 司"）、信达证券股份有限公司（简称"信达证券"）正在筹划由中金公司通过向东兴证券全体A股换股 股东发行A股股票、向信达证券全体A股换股股东发行A股股票的方式换股吸收合并东兴证券、信达证 券（简称"本次重组"）。根据上海证券交易所的相关规定，经公司申请，公司A股股票（证券简称：东 兴证券，证券代码：601198）自2025年11月20日（星期四）开市时起开始停牌。本次重组涉及到A+H股 两地上市公司同时吸收合并两家A股上市公司，涉及事项较多、流程较为复杂，根据上海证券交易所的 相关规定，预计停牌时间不超过25个交易日。鉴于本次重组相关事项存在重大不确定性，为保证信息公 平披露，维护投资者利益，避免造成公司股价异常波动，根据上海证券交易所相关规定，公司A股股票 将继续停牌。 （文章来源：证券日报） ...

（编辑 任世碧） 证券日报网讯 11月26日晚间，中金公司发布公告称，公司与东兴证券股份有限公司（简称"东兴证 券"）、信达证券股份有限公司（简称"信达证券"）正在筹划由公司通过向东兴证券全体A股换股股东 发行A股股票、向信达证券全体A股换股股东发行A股股票的方式换股吸收合并东兴证券、信达证券 （简称"本次重组"）。根据上海证券交易所的相关规定，经公司申请，公司A股股票自2025年11月20日 （星期四）开市时起开始停牌。本次重组涉及到A+H股两地上市公司同时吸收合并两家A股上市公司， 涉及事项较多、流程较为复杂，根据上海证券交易所的相关规定，预计停牌时间不超过25个交易日。鉴 于本次重组相关事项存在重大不确定性，为保证信息公平披露，维护投资者利益，避免造成公司股价异 常波动，根据上海证券交易所相关规定，公司A股股票将继续停牌。停牌期间，公司将积极推进各项工 作，并根据本次重组进展情况，严格按照有关法律法规的规定和要求履行信息披露义务。待相关事项确 定后，公司将及时发布相关公告并申请公司A股股票复牌。 ...

Group 1 - Industrial Fulian adjusts the maximum repurchase price from 19.36 CNY to 75 CNY per share, which is 150% of the average trading price over the last 30 trading days [1] - The company has repurchased a total of 7.6974 million shares, using a total of 147 million CNY [1] - The adjustment aims to ensure the smooth implementation of the repurchase plan and complies with relevant laws and regulations [1] Group 2 - China International Capital Corporation (CICC) continues to suspend trading due to significant uncertainties related to its restructuring with Dongxing Securities and Xinda Securities [2] - The company is planning a share swap to absorb and merge with these two securities firms [2] Group 3 - Shida Group clarifies that it has not initiated any business cooperation with Alibaba Cloud, addressing rumors circulating on online platforms [3] Group 4 - Changguang Huaxin reports uncertainty regarding the sales and profit contributions of several optical communication chips for the current year [4] - The company has achieved mass production of its 100G EML and is in the sampling phase for its 200G EML, but there are risks associated with product development and market expansion [4] Group 5 - Muxi Co., Ltd. announces its initial public offering (IPO) on the Sci-Tech Innovation Board, with a planned issuance of 40.1 million shares [5] - The initial strategic placement is set at 8.02 million shares, with the subscription date on December 5, 2025 [5] Group 6 - Yidong Electronics plans to invest 61.2 million CNY to acquire a 51% stake in Shenzhen Guanding Metal Technology Co., Ltd., focusing on AI server liquid cooling products [6] Group 7 - Zhejiang Pharmaceutical is planning to spin off its subsidiary, Zhejiang Xima Biopharmaceutical Co., Ltd., for a listing on the Hong Kong Stock Exchange to enhance its drug biopharmaceutical segment [7] - The plan is still in the preliminary stages, and specific details are yet to be finalized [7] Group 8 - Meiyan Jixiang's subsidiary has received acceptance for its mineral resource reserve review application from the Ministry of Natural Resources [8] Group 9 - *ST Baoshi's major shareholder plans to increase its stake by up to 0.66%, amounting to no more than 7.515 million shares [9] - The increase will be funded through self-owned or raised funds, with a minimum investment of 21 million CNY [9] Group 10 - Debang Technology reports that the National Integrated Circuit Fund has reduced its stake by 2% from September 11 to October 16, totaling 2.8448 million shares [10] Group 11 - New Sharp Co., Ltd. announces that a shareholder intends to reduce its stake by up to 0.50%, equating to 126.22 million shares, due to personal financial needs [11] Group 12 - China Iron & Steel's major shareholder plans to increase its stake by 65 million to 130 million CNY within six months, having already acquired 596.92 million shares [12] Group 13 - Zhongchuang Co., Ltd. sets the inquiry transfer price at 25.75 CNY per share, with all shares fully subscribed by nine institutional investors [13] Group 14 - Guangdian Yuntong wins a bid for an artificial intelligence application pilot base construction project worth 308 million CNY [14] - Aolaide plans to raise up to 300 million CNY through a private placement for its OLED display core material production base project [14] Group 15 - Tianshan Aluminum announces that the first batch of electrolytic cells for its 1.4 million-ton green low-carbon energy efficiency improvement project has commenced operation [15] - The project aims to enhance the company's electrolytic aluminum production capacity and improve energy efficiency [14]

Group 1: Storage Market Dynamics - The storage spot market is experiencing strong demand, leading to continued price increases for finished products, despite high prices [1] - Customers with low inventory levels are gradually accepting new pricing agreements, providing manufacturers with confidence to raise prices [1] - The significant price increases are affecting retail markets, with online and offline retailers raising prices for memory modules and SSDs, potentially reducing consumer purchasing willingness [1] Group 2: DRAM Industry Forecast - According to TrendForce, the DRAM industry revenue is expected to grow by 30.9% quarter-on-quarter in Q3 2025, reaching $41.4 billion due to rising contract prices and increased shipment volumes [1] - The fourth quarter is anticipated to see a significant increase in contract prices, with conventional DRAM prices expected to rise by 45%-50% [1] - The overall contract prices for conventional DRAM and HBM combined are projected to increase by 50%-55% [1] Group 3: Medical Device Market Growth - The Chinese medical device market is projected to reach ¥1.22 trillion by 2025, with over 33,000 production enterprises expected by the end of 2024, marking a 27.8% increase from the end of the 13th Five-Year Plan [2] - The industry is transitioning from "catching up" to "running alongside and leading," supporting the "Healthy China" strategy [2] Group 4: Flu Season Impact on Pharmaceuticals - The flu season has started early in China, with a 237% increase in sales of Oseltamivir over the past week, and a 180% increase for Maviral [2] - The peak of the flu season is expected between mid-December and early January [2] Group 5: Cinema Industry Growth - As of October 2023, China has added 233 cinemas and 1,588 screens, totaling 15,438 operating cinemas and 92,556 screens nationwide [3] - County-level cinemas account for 21.06% of the total, while town cinemas make up 18.01% [3] Group 6: Innovations in Medical Technology - Novo Nordisk's Kyinsu, the world's first weekly insulin and GLP-1 receptor agonist combination, has been approved in the EU for adults with type 2 diabetes [3] - This innovation represents a significant advancement in diabetes treatment options [3] Group 7: Corporate Developments - Allianz Partners plans to lay off 1,500 to 1,800 employees over the next 12-18 months, primarily in call center roles due to automation [5] - Novartis announced plans to cut up to 550 jobs in Switzerland by the end of 2027 as part of production adjustments [5]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 本公告乃根據香港聯合交易所有限公司證券上市規則第13.10B條而作出。 China International Capital Corporation Limited 中 國 國 際 金 融 股 份 有 限 公 司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：03908） 海外監管公告 债券代码:138664 债券简称:22 中金G1 茲載列中國國際金融股份有限公司（「本公司」）在上海證券交易所網站刊登的本公司2022 年面向專業投資者公開發行公司債券（第一期）（品種一）2025年債券回售實施結果公告， 僅供參閱。 中国国际金融股份有限公司 承董事會命 中國國際金融股份有限公司 董事會秘書 孫男 2022 年面向专业投资者公开发行公司债券 中國，北京 2025年11月26日 (第一期)(品种一)2025年债券回售实施结果公告 於本公告日期，本公司執行董事為陳亮先生及王曙光先生；非執行董事為張 ...

新京报贝壳财经讯 11月26日，信达证券发布公告称，公司正与中金公司、东兴证券筹划重大资产重 组，由中金公司换股吸收合并东兴证券和信达证券。公司A股股票自2025年11月20日开市起停牌，预计 停牌不超25个交易日。鉴于重组事项存在重大不确定性，为维护投资者利益，避免股价异常波动，公司 A股股票将继续停牌。公司将积极推进工作，待事项确定后及时公告并申请复牌。本次重组尚需履行内 部决策程序并获监管批准，存在不确定性。 编辑 杨娟娟 ...

Core Points - The company announced a plan to merge with Dongxing Securities and Cinda Securities through a share exchange, issuing A-shares to all shareholders of both companies [1] - Due to significant uncertainties related to the restructuring, the company's A-shares will remain suspended to ensure fair information disclosure and protect investor interests [1] - The suspension of trading for the company's A-shares began on November 20, 2025, and is expected to last no more than 25 trading days [2] Summary by Category Company Actions - The company is planning a share exchange merger with Dongxing Securities and Cinda Securities [1] - The company will actively advance various tasks during the suspension period and will comply with legal disclosure obligations based on the progress of the restructuring [1] Market Impact - The trading of the company's A-shares has been suspended to prevent abnormal stock price fluctuations [1] - The suspension is in accordance with regulations from the Shanghai Stock Exchange [1]

格隆汇11月26日丨信达证券(601059.SH)公布，公司与中金公司、东兴证券正在筹划由中金公司通过向 东兴证券全体A股换股股东发行A股股票、向信达证券全体A股换股股东发行A股股票的方式换股吸收合 并东兴证券、信达证券。 根据上海证券交易所的相关规定，经公司申请，公司A股股票（证券简称：信达证券，证券代码： 601059）自2025年11月20日（星期四）开市时起开始停牌。 鉴于本次重组相关事项存在重大不确定性，为保证信息公平披露，维护投资者利益，避免造成公司股价 异常波动，根据上海证券交易所相关规定，公司A股股票将继续停牌。 ...

东兴证券公告，公司与中国国际金融股份有限公司、信达证券股份有限公司正在筹划由中金公司通过向 东兴证券全体A股换股股东发行A股股票、向信达证券全体A股换股股东发行A股股票的方式换股吸收合 并东兴证券、信达证券。公司A股股票自2025年11月20日开市时起开始停牌，预计停牌时间不超过25个 交易日。鉴于本次重组相关事项存在重大不确定性，为保证信息公平披露，维护投资者利益，避免造成 公司股价异常波动，根据上海证券交易所相关规定，公司A股股票将继续停牌。 ...